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Folate receptor is a membrane bound protein which is highly expressed by cancer cells 
and macrophages. Folic acid is required for the normal growth of cells and it has been found that 
rapidly growing cancer cells require high levels of folic acid. Folic acid binds to folate receptors 
and through receptor mediated transport folate enters cells. This property has been used to 
synthesize a probe using folate as ligand through polyethylene glycol-Biotin linker. This can be 
used to attach a drug which is ultimately delivered at the site of infectious cells.  The study 
involved here was to determine how folate and magnetic beads can be used to develop imaging 
systems and transport drugs to identify and treat pathologies. Folate-PEG-Biotin probe (already 
synthesized from Dr. Walter Henne and Mr. Rohan Patel) was purified by HPLC and LC/MS 
which was then used to perform cell binding studies with streptavidin coated magnetic beads on 
L1210 type cancer cells. Biotin which is a B-complex vitamin is also required for the growth of 
cells. This biotin has the highest non-covalent affinity to streptavidin in nature and hence was 
used to link streptavidin coated magnetic beads to folate. Polyethylene glycol was used as a 
spacer. This streptavidin protein in the form of magnetic beads captures cells from solution when 
used with the Folate-PEG-Biotin probe. Cells were observed under a high resolution light 
microscope and the images were taken with a high resolution camera available from Dr. Tim 
Gsell’s laboratory. Cells were also studied by just adding streptavidin beads alone to observe if 
they were captured. To another control, Folate-PEG-Biotin/Streptavidin coated magnetic beads 
were added along with 1000 fold excess of folic acid.  
This method is economical and can be used to replace other cancer cell detection techniques. 
Future studies include the conjugation of folate-peg-biotin probe with a proprietary drug 
conjugate to determine the drugs activity on cancer cells which will be carried out at Purdue 
University. 
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Introduction 
Folic Acid: Folic acid (Figure 1) is vitamin B9, and naturally occurs as folate. Folic acid 
shows its activity in the form of its tetrahydrofolate derivative
9
. Folic acid is required for the 
synthesis of DNA and its repair. It is also required as a cofactor in some biological reactions. It is 
required in the body for cell division and growth of cells. Lack of folic acid in the body leads to 
anemia as folate is required for the synthesis of red blood cells. Recent studies provide evidence 
that high levels of folic acid assist in growth of some cancer cells. It has been found that cancer 
cells require folate in order to divide and maintain its functions. 
Folate Receptor: Folate receptor alpha (Figure 3) is a glycophophatidylinositol (GPI) 
membrane bound protein which is encoded by the FOLR1 gene
1
. These kinds of proteins have a 
high affinity towards folic acid and its derivatives and aid in receptor-mediated transport of folic 
acid into the cancer cells. It has been found that tumors of epithelial origin express high FR-
alpha levels than normal cells
2-3
. FR- α receptors are prominently observed in cancers of kidney, 
ovary, lung, colon, lung, brain etc
4
. Studies have shown the presence of folate receptors on many 
different cancerous tissues
5-6
. This enabled researchers to identify the potential of folate 
receptors in targeted drug delivery and diagnosis methods
7-8
. 
 
Streptavidin: It is a protein of the tetramer
10-11
 kind obtained from Streptomyces avidinii. 
It has the high non-covalent binding towards biotin
11
. Its resistance towards organic solvents, 
enzymes, high temperature and pH proves useful for research studies
12
. 
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Here, we used streptavidin coated magnetic beads to isolate cancer cells
13
. Magnetic 
beads are made of iron. Magnetic property of the beads pulls the constructed ligand from the 
solution and also the cells when introduced.    
Biotin: It is a B-complex vitamin which is required for cell growth. Biotin is generally 
used to isolate proteins by linking it to proteins, a process called biotinylation
14
. Biotin has high 
affinity and binds specifically to a protein named streptavidin
15
. This affinity between biotin and 
streptavidin has been used to isolate cancer cells through folate-PEG-biotin.  
Polyethylene Glycol (PEG): It is a polymer of ethylene oxide and in this study, it has 
been used as a spacer between streptavidin and biotin that reduces aggregation by decreasing 
steric hindrance and increases solubility and also reduces toxic and immunological effects.         
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Materials 
a) MagnabindTM Streptavidin from Thermo Scientific: Capacity- 2µg Biotin/ml resin 
Lot no: KH1223234 
Prod # 21344 
b) Biotin-PEG Resin- from Novabiochem 
c) Cancer Cells- L1210 from Purdue University. 
d) RPMI Medium 1640 from Gibco/Invitrogen 
[+]L-Glutamine 
[+]Phenol Red 
[-]Folic acid 
Reference no: 27016-021 
Lot no: 714204 
e) Phosphated Buffered Saline, 1X from Cellgro (Mediatech, Inc) 
Without Calcium and Magnesium 
Cat. No. 21-040-CV 
Lot. No. 21040174 
Exp-      07/2011 
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No. Time 
 
(min) 
% B 
1 0 1 
2 5 1 
3 35 30 
4 45 50 
5 55 60 
6 60 1 
 
Method 
Preparative HPLC of Folate-PEG-Biotin 
The synthesized sample was then purified on a HPLC from Hewlett Packard, series 1050 
equipped with a Diode array detector. 
The following method and parameters were adopted: 
Column: Rigel C18 
Solvent A: Ammonium Bicarbonate Buffer 
Solvent B: Acetonitrile 
Flow Rate: 1ml/min 
Run Time: 60 min.   
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LC/MS Analysis 
Sample from the HPLC run was collected. This sample was then analyzed with LC/MS to 
confirm the identity and purity of the sample through its mass spectra under negative ion mode. 
Column: Eclipse XDB C18 
Solvent for Negative Ion Mode: Methanol and Water. 
Sample Size: 30µl 
Flow Rate: 0.5ml 
Run Time: 10 min 
Scan Range: 600-1000 m/z. 
 
 
 
 
 
 
 
 
Time in min Methanol(%) 
0 30 
1 50 
2 70 
3 90 
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Capture of FR-α Cells With Streptavidin Coated Magnetic Beads 
To 1ml cancer cells, 10µl of purified Folate-PEG-Biotin sample was added. This was 
stirred for 15 minutes at 37degrees (angle) on a mechanical shaker. The sample was then 
centrifuged for a minute. Upon centrifugation, unbound cells separated out at the top and were 
removed with a pipette. To the obtained sample 500µl of PBS was added. This mixture was 
shaken for 15 minutes and then centrifuged for a minute. Clear liquid that separates out at the top 
is removed. This wash with PBS was repeated twice. To the washed sample, 500µl of PBS and 
50µl of streptavidin coated magnetic beads were added. It was then stirred for 15 minutes and 
allowed to stand for 3 minutes on a magnetic stand. Any unbound cells were pipetted out. The 
resulting sample was then washed with PBS, stirred for 15 minutes and centrifuged twice to 
remove any unbound cells.   
Another 1 ml of the same cancer cell type was taken as control. To this, streptavidin 
coated magnetic beads alone were added. To another control, Folate-PEG-Biotin and streptavidin 
coated magnetic beads were added along with 1000-fold excess of folic acid. 
Both the controls and cells under study for capture were observed under a high resolution 
light microscope. 
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Results and Discussion 
The chromatogram described in figure 4 is that of Folate-PEG-Biotin. The large intense 
peak at 37 minutes was proved by the DAD spectrum (figure 5) which shows maximum 
absorbance at 284 and 350nm. Minor peaks adjacent to the main peak are due to some impurities 
present in the sample. To confirm Folate-PEG-Biotin identity, the sample was collected and 
subjected to LC/MS analysis. 
A Purified sample from preparative run from HPLC was collected and analyzed in 
LC/MS. Figure 6 shows an intense peak at 5.2 minutes for LC-DAD. The peak (molecular ion 
peak) at m/z 868 (figure 7) for the negative ion mode matches the calculated value of 869 for 
Folate-PEG-Biotin. This confirms the identity of the purified sample. Peaks at m/z 891 may be 
due to sodium adducts present in glassware or instruments.    
Cells under study were then observed under a light microscope and images were captured 
with a camera. Images obtained confirm that only streptavidin (coated onto magnetic beads) 
conjugated to Folate-PEG-Biotin could capture cells. Cells that were added with streptavidin 
alone (control) could not penetrate the cell membrane. For control-2, excess of folic acid is taken 
up by the cancer cells and hence streptavidin coated magnetic beads could not capture the cancer 
cells. 
Conclusion 
Folate can be used as a ligand for isolation and detection of cells. In this work we were 
able to use magnetic beads to isolate FR+ cancer cells. Since cancer cells express high folate 
receptors and required large amount of folate for metabolism, folate can be used to transport 
drugs into cells by developing folate based ligands for imaging and therapeutic purposes. This 
13 
 
way, folate can be used as a ligand to selectively deliver chemotherapeutic agents. This ensures 
that only impaired cells will have the effects of the drug and normal cells would be left 
untouched. This property of folate can be utilized to develop many more therapeutics agents for 
the cure of various cell related abnormalities and diseases. 
Magnetic beads can be used to isolate cells through linkage to ligands for isolating cells. 
We could easily visualize the cells coated with beads. Thus, we were able to capture and detect 
with the same system. This magnetic property can be used for future studies for developing 
photo-magnetic imaging systems. It is a simple process and economical. This may be combined 
with other down-stream applications besides microscopy such as flow cytometry to count cells 
captured.   
Future Studies 
Further study may involve how folate can be used as a ligand to develop imaging and 
therapeutic agents and delivering drugs specifically at the target. Folate receptor targeted therapy 
is just not limited to cancer but also to large number of diseases. This is mainly because of its 
high expression in tumors and macrophages. Advantages like low cost, ease of handling, 
suitability for use with various agents, “lack of immunogenicity and specificity to pathologic 
cells” makes it a useful agent in studying and developing folate based imaging systems and 
constructing chemotherapeutic agents with ligands for therapeutic purposes.  
Funding 
Funds and equipment were made available by Dr. Walt Henne and Governors State 
University throughout the completion of the project.  
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